prilenia.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.prilenia.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title ABOUT US | Prilenia
Description CONTACT Prilenia Therapeutics is a clinical stage biotech company developing its lead drug candidate, pridopidine, for Huntington’s Disease and ALS. It was founded in 2018 with the purpose of improving the lives of patients and their families by developing
Keywords N/A
Server Information
WebSite prilenia faviconprilenia.com
Host IP 185.230.63.171
Location -
Related Websites
Site Rank
More to Explore
prilenia.com Valuation
US$8,318,456
Last updated: 2023-05-07 07:08:30

prilenia.com has Semrush global rank of 1,272,388. prilenia.com has an estimated worth of US$ 8,318,456, based on its estimated Ads revenue. prilenia.com receives approximately 959,822 unique visitors each day. Its web server is located in -, with IP address 185.230.63.171. According to SiteAdvisor, prilenia.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$8,318,456
Daily Ads Revenue US$7,679
Monthly Ads Revenue US$230,358
Yearly Ads Revenue US$2,764,287
Daily Unique Visitors 63,989
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
prilenia.com. A 3599 IP: 185.230.63.171
prilenia.com. A 3599 IP: 185.230.63.186
prilenia.com. A 3599 IP: 185.230.63.107
prilenia.com. NS 86400 NS Record: ns7.wixdns.net.
prilenia.com. NS 86400 NS Record: ns6.wixdns.net.
prilenia.com. MX 3600 MX Record: 0 prilenia-com.mail.protection.outlook.com.
prilenia.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-07 07:08:30
top of page ABOUT US OUR PEOPLE ABOUT PRIDOPIDINE PUBLICATIONS PIPELINE ABOUT HD ABOUT ALS NEWS CAREERS IMPROVING THE LIVES OF PATIENTS AND THEIR FAMILIES READ MORE ABOUT US WHO WE ARE Prilenia is a clinical stage biotech company, founded and led by Michael Hayden, MBChB, PhD., together with a highly experienced team with a track record of success. Michael is a world-renowned scientist in Huntington Disease research. He is the former President of Global R&D and Chief Scientific Officer at Teva Pharmaceuticals, where he led the development of ~35 new products towards approval in several major markets, predominantly in CNS. ​ The company has raised $144M thus far and is backed by a group of well-respected investors: Forbion, Morningside Venture Investments, Sands Capital, SV Health Investors, Talisman Capital Partners, Sectoral Asset Management, Amplitude Ventures and ALS Investment Fund. Prilenia is a global company with offices in The Netherlands, Israel and The U.S. Pridopidine, the
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Wed, 27 Oct 2021 13:43:00 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.prilenia.com/
strict-transport-security: max-age=120
Age: 67402
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVhT9gRHUF6iCEZerWBFcnqX,m0j2EEknGIVUW/liY8BLLpKOvBhYRuLEqdCLHFrW+6cMbwluI1yUDJty9McxOlfY,2d58ifebGbosy5xc+FRalgw4aDraILIn+jgAvY6q0EU24Eq8r6vD3qF8jl/ysHvZfVDWWVdryuuWkq/vyLnRhg==,2UNV7KOq4oGjA5+PKsX47HYXd6zDG0Q4ZvIB35CKuI8fbJaKSXYQ/lskq2jK6SGP
Cache-Control: no-cache
X-Wix-Request-Id: 1635342180.690470679888223902
X-Content-Type-Options: nosniff

HTTP/2 200 
alt-svc: h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"b34f95ed1ca7b75190e6b3f368570f06"
content-language: en-US
strict-transport-security: max-age=120
x-wix-request-id: 1635342180.821613273129859
cache-control: public,max-age=0,must-revalidate
x-content-type-options: nosniff
server: Pepyaka/1.19.10
accept-ranges: bytes
date: Wed, 27 Oct 2021 13:43:00 GMT
age: 29423
x-served-by: cache-stl4835-STL
x-cache: MISS
vary: Accept-Encoding
server-timing: cache;desc=hit, varnish;desc=hit_miss, dc;desc=fastly
set-cookie: ssr-caching=cache#desc=hit#varnish=hit_miss#dc#desc=fastly; Max-Age=20; Expires=Wed, 27 Oct 2021 05:32:57 GMT
x-seen-by: roqoaVaG/Y0K4FDXPQbYVA==,GXNXSWFXisshliUcwO20NYMupe6WQf6MVMrzEUOojILJ4kc4PZDgZMriFrfXsmvT,qquldgcFrj2n046g4RNSVI5y0OKACGwHEq+Bmxf53RlYgeUJqUXtid+86vZww+nL,2d58ifebGbosy5xc+FRaloxSUcRMZC0SmXWUKyPryyv+SPtCq2oQ10UXNPA8l9PpSf524lPwTgDbn82fURSkbmrGoQYNt6gnPAu2JbQpk4w=,2UNV7KOq4oGjA5+PKsX47EPxNtZAQGoUGD8v2MHQKAJYgeUJqUXtid+86vZww+nL
content-length: 445405
prilenia.com Whois Information
Domain Name: PRILENIA.COM
Registry Domain ID: 2253324138_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2018-12-09T11:58:31Z
Creation Date: 2018-04-17T11:00:26Z
Registry Expiry Date: 2024-04-17T11:00:26Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS6.WIXDNS.NET
Name Server: NS7.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-15T10:38:50Z <<<

Copyright © 2022 WebZZ.US 0.0224